Summaries of the Section H (HML) update

Each month we issue a summary of the HML update. The table on this page gives a preview of the upcoming changes.

The full Update will be available as a PDF on our website(external link) 

The changes will be published in the online HML around the 23rd of this month and are effective from next month.

For any questions about these listing changes or the Pharmaceutical Schedule in general, email us at enquiry@pharmac.govt.nz.

18 January 2022 - preview of changes for February 2022

Pharmaceutical

Change

Barcitinib (Olumiant) tab 2 mg and 4 mg 

new listing

  • tab 2 mg (p’code 2631229)
  • tab 4 mg (p’code 2631237)

Betahistine dihydrochloride tab 16 mg

Brand change

  • Serc – new listing and transfer of HSS (p’code 2611376)
  • Vergo 16 – to be delisted 1 July 2022

Bortezomib inj 2.5 mg vial

presentation to be delisted 1 August 2022

Calcium lactate gluconate with calcium carbonate (e.g. Calcium-Sandoz Forte) tab eff 2.94 g with calcium carbonate 0.3 g (500 mg elemental)

chemical name change

Casirivimab and imdevimab (Ronapreve) inj 120 mg per ml casirivimab, 11.1 ml vial (1) and inj 120 mg per ml imdevimab, 11.1 ml vial (1), 1 treatment pack 

new listing (p’code 2630923)

Clonidine hydrochloride (Clonidine Teva) tab 25 mcg

new listing (p’code 2630249)

Megestrol acetate (Megace) tab 160 mg

new listing and to be delisted 1 February 2023 (p’code 2630966)

Mivacurium chloride (Mivacron) inj 2 mg per ml, 5 ml ampoule

brand to be delisted 1 August 2022

Mivacurium chloride (Mivacron) inj 2 mg per ml, 10 ml ampoule  

brand delisted 1 February 2022

Oxycodone hydrochloride

  • inj 10 mg per ml, 1 ml and 2 ml ampoule
  • inj 50 mg per ml, 1 ml ampoule

Brand change

Hameln– new listing and addition of PSS

  • inj 10 mg per ml, 1 ml ampoule (p’code 2631172)
  • inj 10 mg per ml, 2 ml ampoule (p’code 2631180)
  • inj 50 mg per ml, 1 ml ampoule (p’code 2631199)

Oxynorm – to be delisted 1 July 2022

Oxazepam (Ox-Pam) tab 10 mg and 15 mg

brand to be delisted 1 April 2022

Nicotine

  • oral spray 1 mg per dose (e.g. Nicorette QuickMist Mouth Spray)
  • soln for inhalation 15 mg cartridge (e.g. Nicorette Inhalator) 

amended restriction criteria

Paediatric oral feed 1 kcal/ml (Pediasure (Chocolate, Strawberry and Vanilla)) liquid 2.8 g protein, 11.2 g carbohydrate and 5 g fat per 100 ml, bottle

presentation description change

Paediatric oral feed 1 kcal/ml (Pediasure (Vanilla)) liquid 2.8 g protein, 11.2 g carbohydrate and 5 g fat per 100 ml, can, 250 ml

presentation description change

Paediatric oral feed 1.5 kcal/ml (e.g. Pediasure Plus) liquid 4.2 g, 16.7 g carbohydrate and 7.5 g fat per 100 ml, 500 ml bottle

new listing

Sunitinib cap 12.5 mg, 25 mg and 50 mg

Brand change

Sunitinib Pfizer– new listing and addition of PSS

  • cap 12.5 mg (p’code 2630303)
  • cap 25 mg (p’code 2630311)
  • cap 50 mg (p’code 2630338)

Sutent – to be delisted 1 July 2022

Tocilizumab (Actemra) inj 20 mg per ml, 4 ml vial, 10 ml vial and 20 ml vial

amended restriction criteria